Ozelle to Showcase AI-Powered Diagnostic Insights from Blood Morphology at WHX Labs Dubai 2026

236505f573920a3ef421fc0e065fb582 From Morphology to Clinical Insights: Ozelle's AI-Powered Diagnostics at WHX Labs Dubai 2026

DUBAI, UAE, Feb. 10, 2026 — On the opening day of WHX Labs Dubai 2026, attendees are encouraged to visit Booth S1.D58 to discover how Ozelle converts diagnostic testing into interactive, decision-supporting workflows. The integrated system, themed “AI × CBM: The Next-Generation of Complete Blood Morphology,” merges high-resolution morphology analysis with AI-driven workflows and pre-configured panels to enable assured clinical choices.

Ozelle the next standard in diagnostic testing-WHX Dubai

AI Workbench: Converting Reports into Actionable Insights

The focal point of Ozelle’s exhibition is the Intelligent AI Workbench (Open Dx) — a unified diagnostic environment built directly into the analyzer. This workspace processes unrefined laboratory data into organized, interactive findings that direct clinicians toward practical information.

Core functionalities encompass risk categorization, conversational AI for explaining reports, urgent notifications, and longitudinal trend monitoring. By unifying test requests, results evaluation, and AI-guided analysis within one straightforward process, the workbench facilitates prompt and certain decisions, eliminating extra operational strain or the need for significant training.

Broadening Applications: From Standard Care to Malaria Screening

Live exhibits will showcase the system’s adaptability:

  • Infection Profiling: Conducts CBC, CRP, and SAA tests in one automated sequence, removing the need for manual reagent changes.
  • Everyday Disease Management: Offers adaptable, configurable panels for monitoring diabetes, cardiac, and thyroid conditions, engineered for repeated, frequent use without complicating the workflow.
  • Malaria Risk Screening: Utilizes AI-based morphology assessment to detect red blood cell patterns linked to Plasmodium, delivering risk level indications (high, medium, low) for preliminary screening and subsequent action in areas where the disease is common.

These application-specific features show how Ozelle applies sophisticated morphology intelligence past standard CBC testing to aid in both daily healthcare and critical public health initiatives.

AI × CBM: Proven, Dependable, and User-Friendly

The core of Ozelle’s system is its AI-enhanced Complete Blood Morphology (CBM), which fuses high-definition imaging with instant algorithmic processing to yield profound, practical insights. Paired with a design that is maintenance-free and simple to operate, the system provides consistent, long-lasting performance, making it well-suited for primary care facilities, laboratory networks, and decentralized testing locations.

The technology’s validity is supported by more than 50,000 installations worldwide, which produce over 50 million cell images each day and accumulate more than 100 billion data points from actual use. Ongoing enhancement of algorithms through a unique quality assurance framework guarantees laboratory-standard accuracy that is consistent, expandable, and durable.

Guests can participate in live demonstrations, practical sessions with the AI Workbench, and detailed conversations about distribution partnerships and local implementation plans with the Ozelle team. to see Ozelle’s AI-driven diagnostics in action.

Contact Ozelle

Photo –

jones